Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.
作者信息
Hickman Heather D, Yewdell Jonathan W
机构信息
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18747-8. doi: 10.1073/pnas.1013851107. Epub 2010 Oct 25.
Abstract
摘要
相似文献
1
Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18747-8. doi: 10.1073/pnas.1013851107. Epub 2010 Oct 25.
2
Soluble plasma HLA peptidome as a potential source for cancer biomarkers.
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18769-76. doi: 10.1073/pnas.1008501107. Epub 2010 Oct 25.
3
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Mol Cell Proteomics. 2019 Jun;18(6):1255-1268. doi: 10.1074/mcp.RA119.001524.
4
Immunotherapy: natural versus synthetic peptides.
Immunol Today. 1998 Feb;19(2):98.
5
Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Eur J Immunol. 2014 Mar;44(3):774-84. doi: 10.1002/eji.201343671. Epub 2013 Dec 27.
6
Long-lasting cross-presentation of tumor antigen in human DC.
Eur J Immunol. 2009 Feb;39(2):380-90. doi: 10.1002/eji.200838669.
7
The identification of cancer antigens: impact on the development of cancer vaccines.
Cancer J. 2000 Apr;6 Suppl 2:S142-9.
8
Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Nature. 2022 Jul;607(7917):149-155. doi: 10.1038/s41586-022-04839-2. Epub 2022 Jun 15.
9
Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
Immunol Cell Biol. 2011 Nov;89(8):904-13. doi: 10.1038/icb.2011.13. Epub 2011 Mar 8.
10
High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array.
J Immunol. 2020 Mar 15;204(6):1689-1696. doi: 10.4049/jimmunol.1900889. Epub 2020 Feb 14.
引用本文的文献
1
The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design.
Vaccines (Basel). 2020 Dec 18;8(4):775. doi: 10.3390/vaccines8040775.
2
Keratin 8 is a potential self-antigen in the coronary artery disease immunopeptidome: A translational approach.
PLoS One. 2019 Feb 27;14(2):e0213025. doi: 10.1371/journal.pone.0213025. eCollection 2019.
3
The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.
PLoS One. 2017 Nov 1;12(11):e0187432. doi: 10.1371/journal.pone.0187432. eCollection 2017.
4
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.
Mol Cell Proteomics. 2015 Dec;14(12):3105-17. doi: 10.1074/mcp.O115.052431.
5
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology.
J Vis Exp. 2015 Mar 24(97):52159. doi: 10.3791/52159.
6
Therapeutic vaccines for cancer: an overview of clinical trials.
Nat Rev Clin Oncol. 2014 Sep;11(9):509-24. doi: 10.1038/nrclinonc.2014.111. Epub 2014 Jul 8.
7
The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing.
Mol Cell Proteomics. 2011 Oct;10(10):O111.011833. doi: 10.1074/mcp.O111.011833. Epub 2011 Aug 2.
本文引用的文献
1
Soluble plasma HLA peptidome as a potential source for cancer biomarkers.
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18769-76. doi: 10.1073/pnas.1008501107. Epub 2010 Oct 25.
2
The hidden benefits of sex: evidence for MHC-associated mate choice in primate societies.
Bioessays. 2010 Nov;32(11):940-8. doi: 10.1002/bies.201000066. Epub 2010 Sep 9.
3
Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy.
Int J Cancer. 2010 Oct 1;127(7):1637-42. doi: 10.1002/ijc.25374.
4
Regulation of MHC class I assembly and peptide binding.
Annu Rev Cell Dev Biol. 2008;24:343-68. doi: 10.1146/annurev.cellbio.24.110707.175347.
5
Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
Tissue Antigens. 2008 Oct;72(4):321-34. doi: 10.1111/j.1399-0039.2008.01106.x. Epub 2008 Aug 12.
6
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
Curr Opin Immunol. 2007 Apr;19(2):203-8. doi: 10.1016/j.coi.2007.02.001. Epub 2007 Feb 9.
7
Clonal origin and evolution of a transmissible cancer.
Cell. 2006 Aug 11;126(3):477-87. doi: 10.1016/j.cell.2006.05.051.
8
The DRiP hypothesis decennial: support, controversy, refinement and extension.
Trends Immunol. 2006 Aug;27(8):368-73. doi: 10.1016/j.it.2006.06.008. Epub 2006 Jul 11.
9
Immune selective pressure and HLA class I antigen defects in malignant lesions.
Cancer Immunol Immunother. 2007 Feb;56(2):227-36. doi: 10.1007/s00262-006-0183-1. Epub 2006 Jun 17.
10
Unanticipated antigens: translation initiation at CUG with leucine.
PLoS Biol. 2004 Nov;2(11):e366. doi: 10.1371/journal.pbio.0020366. Epub 2004 Oct 26.
Zotero 插件